Health Sciences Research Awards and Grants
* Award dollars are not included in the clinical trials, as funds are earned based upon completion of study milestones and enrollment.
| Title | Type | $ Amount | Activity | Investigator | Unit | Sponsor | Date |
|---|---|---|---|---|---|---|---|
| Inflammatory Bowel Disease (IBD) West Case Conference | Grant | 10,000.00 | Instruction | Sasha Taleban | Medicine | Miscellaneous | 12/2024 |
| IPA for Analisa Stewart | Contract | 37,290.00 | Research | Kristian Doyle | Immunobiology | United States Department of Veterans Affairs | 12/2024 |
| IPA for Danielle Becktel | Contract | 72,466.00 | Research | Kristian Doyle | Immunobiology | United States Department of Veterans Affairs | 12/2024 |
| Medical Marijuana Poison Control | Contract | 1,450,000.00 | Other Sponsored Activity | Steven Dudley | COM Phx Ctr Tox&Pharm Ed&Res | Arizona Department of Health Services | 12/2024 |
| ML44719, a Phase II, Open-label, Multi-cohort, Multicenter Study in Patients with Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis | Contract | * | Clinical Trial | Junaid Arshad | Cancer Center Division | Syneos Health | 12/2024 |
| Neighborhood Built and Social Environments and Cancer Risk in the U.S | Grant | 1,200,000.00 | Research | Chris Chaeha Lim | Community Environment & Policy | American Cancer Society | 12/2024 |
| Pima County Community and Rural Vax Effort (CRVE): Empowering Youth and CHWs to Bridge Urban, Tribal, and Rural COVID-19 Vaccination Gaps | Contract | 100,000.00 | Other Sponsored Activity | Sheila Soto | Public Hlth Prac & Trans Rsch | Pima County Health Department | 12/2024 |
| SVPEP U OF A PREVENTION RESEARCH CENTER(AZPRC) | Contract | 50,294.00 | Other Sponsored Activity | Kathryn Ortiz y Pino | Health Promotion Sciences | Arizona Department of Health Services | 12/2024 |
| Systems Biological Assessment of the Durability of Vaccine Responses | Cooperative Agreement | 44,725.00 | Research | Prabhu Arunachalam | Immunobiology | Stanford University | 12/2024 |
| Task Area C, Option 2 Reobligation (CLIN 12 of Prime Award) | Grant | 15,000.00 | Research | John Galgiani | Valley Fever Ctr for Excellnc | Duke University | 12/2024 |
| Unraveling the Genetic Architecture of Cochleovestibular Malformation | Grant | 1,176,994.00 | Research | Isabelle Schrauwen | COM Phx Translational Neurosci | National Institute on Deafness and Other Communication Disorders | 12/2024 |
| WTS Mid-Career Investigator Award: Lung Cancer, Exercise and the Tumor Microenvironment | Grant | 50,000.00 | Research | Stephanie Worrell | Surgery | American Association for Thoracic Surgery | 12/2024 |
| A Phase 1/2 Open-Label, Umbrella Platform Design of lnvestigational Agents With or Without Pembrolizumab (MK-3475) and/or Chemotherapy in Participants With Advanced Gastroesophageal Cancer: Master (KE | Contract | * | Clinical Trial | Junaid Arshad | Cancer Center Division | Merck Sharp & Dohme Corp. | 11/2024 |
| A Phase 1b/2a, Double-Blind, Placebo-Controlled, Three Arm, Randomized Study Evaluating Continuous Infusion of LSTA1 Over 4 Hours When Added to Standard of Care (SoC) Versus a Single Intravenous (IV) | Contract | * | Clinical Trial | Rachna Shroff | Cancer Center Division | Lisata Therapeutics | 11/2024 |
| A Phase Ib/III, Open-label, Randomised Study of Capivasertib plus CDK4/6 Inhibitors and Fulvestrant versus CDK4/6Inhibitors and Fulvestrant in Hormone Receptor-Positive and Human Epidermal Growth Fact | Contract | * | Clinical Trial | Umbreen Rozell | Cancer Center Division | Astrazeneca | 11/2024 |
| A Research Study to Advance the CF Therapeutics Pipeline for People without Modulators | Contract | * | Clinical Trial | Cori Daines | Asthma/Airway Disease Rsch Ctr | Seattle Children's Hospital | 11/2024 |
| A Two-Arm Randomized, Double-Blind, Placebo- Controlled Phase 2 Selection Trial to Evaluate the Efficacy and Safety of VB10.16 Alone or in Combination with Atezolizumab in Patients with HPV16-Positive | Contract | * | Clinical Trial | Marina Miller | Cancer Center Division | GOG Foundation, Inc. | 11/2024 |
| An Open-Label Extension Study to Assess the Safety, Tolerability, and Effectiveness of the Long-Term Use of Treprostinil Palmitil Inhalation Powder in Participants with Pulmonary Arterial Hypertension | Contract | * | Clinical Trial | Nafis Shamsid-Deen | COM Phx Internal Medicine | Insmed Incorporated | 11/2024 |
| An Open-label Single-Arm Phase IIb Study of F901318 as Treatment of Invasive Fungal Infections Due to Lomentospora Prolificans, Scedosporium Spp., Aspergillus Spp., and Other Resistant Fungi in Patien | Contract | * | Clinical Trial | Fariba Donovan | Medicine | IQVIA RDS Inc. | 11/2024 |
| Analysis of immunologic mechanisms in patients with chronic lung disease after acute COVID infection | Grant | 540,280.00 | Research | Janko Nikolich | Immunobiology | Indiana University | 11/2024 |
* Award dollars are not included in the clinical trials, as funds are earned based upon completion of study milestones and enrollment.